- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Statement of Comprehensive Income
- Analysis of Liquidity Ratios
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
| 12 months ended: | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Federal | |||||||||||
| State | |||||||||||
| Foreign | |||||||||||
| Current taxes | |||||||||||
| Federal | |||||||||||
| State | |||||||||||
| Foreign | |||||||||||
| Deferred taxes | |||||||||||
| Provision for income taxes |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The provision for income taxes demonstrates fluctuating behavior over the five-year period. Current tax expense consistently represents the larger component of the total provision, while deferred tax expense acts as a partial offset.
- Current Taxes
- Current tax expense increased significantly from 2021 to 2022, more than doubling from US$542.9 million to US$1,186.3 million. This increase suggests a corresponding rise in pre-tax income. The expense remained substantial in 2023 at US$1,296.7 million, before decreasing to US$1,132.9 million in 2024. A slight increase is observed in 2025, reaching US$1,200.8 million. Overall, current taxes exhibit a generally high and relatively stable trend, with some year-to-year variation.
- Deferred Taxes
- Deferred tax expense is consistently negative, representing a deferred tax benefit. The magnitude of this benefit increased from US$154.6 million in 2021 to US$275.9 million in 2022. The benefit grew substantially in 2023 to US$536.5 million, indicating a larger impact from temporary differences or carryforwards. The benefit decreased to US$348.8 million in 2024, and then increased again to US$510.8 million in 2025. The increasing trend in the deferred tax benefit suggests a growing impact of items creating deferred tax assets.
- Provision for Income Taxes
- The provision for income taxes, calculated as the sum of current and deferred taxes, follows the trends of its components. It rose from US$388.3 million in 2021 to US$910.4 million in 2022, then decreased to US$760.2 million in 2023. The provision increased slightly to US$784.1 million in 2024, and decreased again to US$690.0 million in 2025. The fluctuations in the provision align with the changes in both current and deferred tax components, suggesting a dynamic tax position influenced by pre-tax income and temporary differences.
The relationship between current and deferred taxes indicates that while the company consistently pays income taxes, deferred tax benefits partially offset the overall tax liability. The increasing deferred tax benefits over the period suggest a growing utilization of tax planning strategies or the recognition of future tax benefits.
Effective Income Tax Rate (EITR)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Federal statutory tax rate | ||||||
| Effective tax rate |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The effective income tax rate exhibited considerable fluctuation over the five-year period. While the federal statutory tax rate remained constant at 21.00%, the effective tax rate varied significantly, suggesting influences beyond the standard corporate tax structure.
- Effective Tax Rate Trend
- In 2021, the effective tax rate was 14.20%, notably below the statutory rate. This indicates the presence of tax benefits or credits reducing the company’s tax burden. The rate increased to 21.50% in 2022, approaching the statutory rate, potentially reflecting a decrease in those benefits or a change in the company’s earnings mix. A decrease to 17.40% was observed in 2023, continuing the pattern of fluctuation. However, 2024 saw a dramatic increase to 315.50%, a substantial outlier. This exceptionally high rate warrants further investigation, potentially stemming from a one-time event such as the recognition of a deferred tax liability or a significant change in tax law impacting previously unrecognized tax benefits. Finally, the effective tax rate decreased substantially in 2025 to 14.90%, returning to a level similar to that observed in 2021.
- Discrepancy from Statutory Rate
- The consistent difference between the effective tax rate and the federal statutory rate throughout most of the period suggests the company benefits from items such as tax credits, deductions, or differing tax rates in jurisdictions where it operates. The magnitude of this difference varied, with the largest deviation occurring in 2024, further emphasizing the unusual nature of the tax expense in that year.
- 2024 Anomaly
- The 315.50% effective tax rate in 2024 is a significant deviation from the trend and the statutory rate. This requires detailed examination of the underlying income tax provision to understand the specific drivers. Potential causes include, but are not limited to, the reversal of previously recognized tax benefits, the impact of international tax regulations, or a one-time tax expense related to a specific transaction.
Overall, the effective tax rate demonstrates a lack of consistent pattern, with the exception of the substantial increase in 2024. Continued monitoring of the effective tax rate and its components is recommended to understand the factors influencing the company’s tax obligations.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The composition of deferred tax assets and liabilities demonstrates a consistent increase over the five-year period. A significant driver of this growth is the accumulation of tax credit carryforwards, which increased steadily from US$202.4 million in 2021 to US$355.8 million in 2025. Concurrent with this, substantial increases are observed in components related to research and development (R&D) capitalization, beginning in 2022 and accelerating through 2025, reaching US$1,920.5 million. Stock-based compensation also contributes to the deferred tax asset base, showing a consistent, though less dramatic, increase.
- Tax Credit Carryforwards
- Tax credit carryforwards exhibit a consistent upward trend throughout the period, indicating a sustained ability to utilize these credits against future taxable income. The growth suggests ongoing investment and activities generating these credits.
- Intangible Assets
- The value associated with intangible assets initially decreased from 2021 to 2022, before showing modest increases in subsequent years. However, by 2025, the value decreased to US$651.6 million, representing a significant decline from the 2021 level. This fluctuation may be related to amortization, impairment, or changes in the valuation of these assets.
- R&D Capitalization
- R&D capitalization is the most significant contributor to the growth in deferred tax assets, particularly from 2022 onwards. The substantial increase from US$438.3 million in 2022 to US$1,920.5 million in 2025 suggests a considerable and growing investment in research and development activities. This is a key driver of the overall increase in deferred tax assets.
- Valuation Allowance
- The valuation allowance against deferred tax assets has increased each year, from US$220.4 million in 2021 to US$326.2 million in 2025. This suggests a growing level of uncertainty regarding the realization of a portion of the deferred tax assets, despite the overall increase in their gross amount. The consistent increase warrants monitoring to assess the potential impact on future tax benefits.
- Deferred Tax Liabilities
- Deferred tax liabilities, primarily driven by operating lease liabilities and other items, have also increased over the period, though at a slower rate than the deferred tax assets. Operating lease liabilities show a substantial increase beginning in 2023, contributing significantly to the growth in deferred tax liabilities. The 'Other' component of deferred tax liabilities decreased over the period.
- Net Deferred Tax Position
- The net deferred tax position remains a net asset throughout the period, increasing substantially from US$934.5 million in 2021 to US$2,897.9 million in 2025. This indicates a future reduction in tax payments, assuming the deferred tax assets are realized. The consistent growth in the net deferred tax asset position reflects the company’s ability to generate future tax benefits from current deductible temporary differences and carryforwards.
In summary, the deferred tax asset base is expanding, largely due to increasing R&D capitalization and tax credit carryforwards. While the valuation allowance is also increasing, the net deferred tax position remains strongly positive, suggesting a future tax benefit. The growth in deferred tax liabilities, particularly related to operating leases, is less pronounced but still contributes to the overall picture.
Deferred Tax Assets and Liabilities, Classification
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The deferred tax assets exhibited a consistent upward trend over the five-year period. A substantial increase is observed each year, indicating a growing potential for future tax benefits.
- Overall Trend
- The value of deferred tax assets increased steadily from US$934.5 million in 2021 to US$2.898 billion in 2025. This represents a cumulative growth of approximately 209.8% over the period.
- Year-over-Year Changes
- From 2021 to 2022, deferred tax assets increased by US$312.4 million, representing a growth of 33.4%. The increase from 2022 to 2023 was US$565.2 million, a growth of 45.3%. The growth continued from 2023 to 2024 with an increase of US$519.0 million, or 28.6%. Finally, from 2024 to 2025, deferred tax assets grew by US$566.8 million, representing a 24.3% increase.
- Growth Rate Analysis
- While the absolute increase in deferred tax assets is consistently positive, the year-over-year growth rate decelerates slightly from 2021-2023, before stabilizing in the last two years. The highest growth rate occurred between 2022 and 2023, while the lowest occurred between 2024 and 2025. This suggests that the rate of generating future taxable differences or loss carryforwards may be moderating.
The consistent growth in deferred tax assets suggests the company is either generating more temporary differences between its accounting and tax bases, or is utilizing net operating loss carryforwards. Further investigation into the specific components of these deferred tax assets would be necessary to understand the underlying drivers of this trend.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial information reveals adjustments made to reported figures, specifically concerning the removal of deferred tax assets and liabilities. These adjustments impact total assets, shareholders’ equity, and net income over the five-year period. A consistent pattern emerges where adjusted figures are lower than reported figures each year, indicating a reduction resulting from the removal of deferred tax items.
- Total Assets
- Reported total assets demonstrate an increasing trend from 2021 to 2023, peaking at US$22,730.2 million, before decreasing slightly in 2024 to US$22,533.2 million and then increasing again in 2025 to US$25,643.0 million. The adjusted total assets follow a similar pattern, consistently lower than the reported values, starting at US$12,498.0 million in 2021 and reaching US$22,745.1 million in 2025. The difference between reported and adjusted total assets remains relatively stable in absolute terms, fluctuating between approximately US$1.0 million and US$1.2 million annually.
- Shareholders’ Equity
- Reported shareholders’ equity also exhibits an upward trend from 2021 to 2023, rising from US$10,100.0 million to US$17,580.4 million, followed by a decrease in 2024 to US$16,409.6 million, and a subsequent increase to US$18,665.8 million in 2025. Adjusted shareholders’ equity mirrors this trend, consistently below the reported figures, beginning at US$9,165.5 million in 2021 and reaching US$15,767.9 million in 2025. The gap between reported and adjusted shareholders’ equity also remains relatively consistent, ranging from approximately US$934.5 million to US$1,147.1 million annually.
- Net Income
- Reported net income increases from US$2,342.1 million in 2021 to US$3,619.6 million in 2023, then experiences a significant loss of US$535.6 million in 2024, before recovering to a profit of US$3,953.2 million in 2025. The adjusted net income follows a similar trajectory, with a reduction in reported values, starting at US$2,187.5 million in 2021 and reaching US$3,083.1 million in 2023, a loss of US$884.4 million in 2024, and a profit of US$3,442.4 million in 2025. The adjustment to net income appears to be relatively consistent, reducing the reported amount by approximately US$154.6 million to US$275.9 million each year. The largest difference is observed in 2024, where the adjustment reduces the reported loss by US$349.8 million.
The consistent reduction in all three financial statement items – total assets, shareholders’ equity, and net income – through the adjustments suggests a systematic removal of deferred tax items. The magnitude of the adjustments remains relatively stable over the period, indicating a consistent approach to this accounting treatment. The significant impact on net income in 2024, where the adjustment lessened the reported loss, highlights the potential materiality of these deferred tax adjustments to the company’s financial performance.
Vertex Pharmaceuticals Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial performance metrics exhibit notable shifts when deferred tax impacts are removed, resulting in adjusted ratios. Generally, the adjusted ratios present a slightly different, and in some cases, more conservative view of the company’s financial health compared to the reported figures. A consistent pattern isn’t immediately apparent across all ratios, but certain trends emerge when examining individual metrics over the five-year period.
- Profitability
- Reported net profit margin increased from 30.92% in 2021 to 37.20% in 2022, before declining sharply to -4.86% in 2024, and recovering to 32.94% in 2025. The adjusted net profit margin follows a similar trajectory, though the magnitude of the decline in 2024 is more pronounced, reaching -8.03%. This suggests that deferred tax assets or liabilities significantly influence reported profitability, and their removal reveals a potentially more volatile underlying profit picture. The difference between reported and adjusted margins is relatively small in 2021-2023, but widens considerably in 2024 and 2025.
- Asset Efficiency
- Reported total asset turnover demonstrates a gradual decline from 0.56 in 2021 to 0.43 in 2023, followed by a slight recovery to 0.49 in 2024 and 0.47 in 2025. The adjusted total asset turnover shows a similar pattern, but consistently reports higher values than the reported ratio, indicating that the removal of deferred tax assets improves the apparent efficiency of asset utilization. The difference between the reported and adjusted ratios remains relatively stable over the period.
- Financial Leverage
- Reported financial leverage remains relatively stable between 1.30 and 1.37 over the period. The adjusted financial leverage is slightly higher than the reported leverage in each year, increasing from 1.36 in 2021 to 1.44 in 2025. This indicates that removing deferred tax impacts slightly increases the apparent level of financial risk, as measured by leverage.
- Return on Investment
- Reported Return on Equity (ROE) mirrors the trend in net profit margin, peaking at 23.88% in 2022, falling to -3.26% in 2024, and recovering to 21.18% in 2025. The adjusted ROE exhibits a similar pattern, with a more substantial decline in 2024 (-6.28%). The same observation applies to Return on Assets (ROA); reported ROA declines to -2.38% in 2024, while the adjusted ROA falls to -4.38%. The removal of deferred tax effects consistently results in lower ROE and ROA figures, particularly during the period of negative reported profitability in 2024. This suggests that deferred taxes are currently providing a boost to reported returns, which is diminished when considering the adjusted figures.
In summary, the adjusted ratios generally present a more conservative assessment of financial performance. The most significant impact of removing deferred tax effects is observed in the profitability and return ratios, particularly in 2024, where the adjusted figures reveal a more substantial decline than the reported figures. The impact on asset turnover and financial leverage is less pronounced, but consistently indicates a slight adjustment in the perceived efficiency and risk profile.
Vertex Pharmaceuticals Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Net profit margin = 100 × Net income (loss) ÷ Revenues
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Revenues
= 100 × ÷ =
The adjusted net profit margin exhibited fluctuations over the five-year period. Initial increases were followed by a significant decline and subsequent recovery. A comparison with the reported net profit margin reveals consistent patterns, though with differing magnitudes.
- Adjusted Net Profit Margin Trend
- The adjusted net profit margin began at 28.88% in 2021, increasing to 34.11% in 2022. A subsequent decrease to 31.24% occurred in 2023. A substantial decline was observed in 2024, with the margin falling to -8.03%, indicating a net loss when considering adjustments. The margin recovered to 28.68% in 2025, though remaining below the levels seen in 2022.
- Comparison with Reported Net Profit Margin
- The reported net profit margin mirrored the trend of the adjusted net profit margin, starting at 30.92% in 2021 and peaking at 37.20% in 2022. It then decreased to 36.68% in 2023 before experiencing a more dramatic drop to -4.86% in 2024. The reported margin also showed recovery in 2025, reaching 32.94%. The difference between the reported and adjusted margins remained relatively consistent across the years, suggesting that the adjustments applied consistently impacted profitability.
- Year-over-Year Changes
- From 2021 to 2022, the adjusted net profit margin increased by 5.23 percentage points. The subsequent year saw a decrease of 2.87 percentage points. The most significant change occurred between 2023 and 2024, with a decrease of 39.27 percentage points. Finally, from 2024 to 2025, the adjusted net profit margin increased by 36.71 percentage points.
The substantial decline in 2024, impacting both reported and adjusted margins, warrants further investigation to understand the underlying factors contributing to the loss. The recovery in 2025 suggests a potential reversal of those factors, but continued monitoring is recommended to assess the sustainability of this improvement.
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Revenues ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Revenues ÷ Adjusted total assets
= ÷ =
An examination of the provided financial information reveals trends in both total asset values and associated turnover ratios over a five-year period. Reported total assets demonstrate a consistent increase from 2021 to 2023, followed by a slight decrease in 2024 and a subsequent increase in 2025. Adjusted total assets mirror this pattern, exhibiting growth through 2023, a decline in 2024, and renewed growth in 2025, though at a slightly lower magnitude than the reported assets.
- Reported Total Asset Turnover
- The reported total asset turnover ratio experienced a decline from 0.56 in 2021 to 0.43 in 2023, indicating decreasing efficiency in generating revenue from reported assets. A modest recovery to 0.49 was observed in 2024, followed by a slight decrease to 0.47 in 2025. This suggests a stabilization, but not a significant improvement, in the utilization of reported assets.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio followed a similar trajectory, decreasing from 0.61 in 2021 to 0.47 in 2023. However, the ratio demonstrated a more pronounced increase in 2024, reaching 0.55, before settling at 0.53 in 2025. The adjusted ratio consistently remained higher than the reported ratio throughout the period, suggesting that excluding certain asset components results in a more favorable assessment of asset efficiency.
The divergence between reported and adjusted asset turnover ratios highlights the impact of the asset adjustments. The greater volatility observed in the adjusted ratio, particularly the increase in 2024, suggests that the adjustments are materially affecting the turnover calculation. The overall trend indicates a potential challenge in effectively utilizing assets to generate revenue, although the adjustments offer a somewhat more optimistic perspective. The stabilization of both ratios in the later years suggests a potential plateau in operational efficiency.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= ÷ =
An examination of the financial information reveals trends in both reported and adjusted asset and equity figures, impacting calculated financial leverage ratios over the five-year period. Reported total assets increased from 2021 to 2023, then experienced a slight decrease in 2024 before rising again in 2025. Adjusted total assets followed a similar pattern, though the magnitude of change was consistently lower than that of the reported figures. Shareholders’ equity, both reported and adjusted, generally increased throughout the period, with a dip observed in reported equity in 2024, mirroring the trend in total assets.
- Adjusted Financial Leverage
- Adjusted financial leverage exhibited an increasing trend from 2021 to 2025. Starting at 1.36 in 2021, it remained relatively stable at 1.33 in both 2022 and 2023. A noticeable increase occurred in 2024, reaching 1.43, and continued to rise to 1.44 in 2025. This suggests a growing reliance on financial leverage when considering adjustments to the asset and equity base.
- Relationship between Reported and Adjusted Leverage
- Reported financial leverage fluctuated more than adjusted financial leverage. While reported leverage decreased slightly from 1.33 in 2021 to 1.29 in 2023, it increased to 1.37 in both 2024 and 2025. The difference between reported and adjusted leverage widened over time, indicating that the adjustments made to assets and equity have a growing impact on the overall leverage profile. The adjustments consistently result in a higher leverage ratio than the reported figures.
The consistent difference between reported and adjusted figures suggests the presence of items impacting the balance sheet that are being adjusted for in this analysis. The upward trend in adjusted financial leverage, particularly in the later years, warrants further investigation to understand the underlying drivers and potential implications for the company’s financial risk.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net income (loss) ÷ Shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income (loss) ÷ Adjusted shareholders’ equity
= 100 × ÷ =
The period between 2021 and 2025 demonstrates fluctuating financial performance as reflected in both reported and adjusted return on equity (ROE). Reported net income increased from 2021 to 2023, then experienced a significant loss in 2024 before recovering in 2025. Adjusted net income followed a similar pattern, though the magnitude of the loss in 2024 was larger on an adjusted basis. Shareholders’ equity, both reported and adjusted, generally increased over the period, with a slight decrease in reported shareholders’ equity from 2023 to 2024.
- Reported ROE
- Reported ROE exhibited an initial increase from 23.19% in 2021 to 23.88% in 2022. A subsequent decline to 20.59% occurred in 2023. The most substantial change was a significant decrease to -3.26% in 2024, indicating a net loss relative to shareholders’ equity. ROE recovered to 21.18% in 2025, though remaining below the levels observed in 2021 and 2022.
- Adjusted ROE
- Adjusted ROE mirrored the trend of reported ROE, beginning at 23.87% in 2021 and rising to 24.05% in 2022. It then decreased to 19.55% in 2023. The adjusted ROE experienced a more pronounced decline in 2024, reaching -6.28%, reflecting the larger adjusted net loss. A recovery to 21.83% was observed in 2025, again falling short of the earlier peak values.
- Relationship between Reported and Adjusted ROE
- The difference between reported and adjusted ROE remained relatively consistent across the years, generally with the adjusted ROE being slightly higher. This suggests that adjustments to net income and shareholders’ equity consistently impact the ROE calculation in the same direction. The larger divergence in 2024, with a more substantial decline in adjusted ROE, highlights the impact of the adjustments during that period of net loss.
- Shareholders’ Equity Impact
- The growth in shareholders’ equity from 2021 to 2025 generally supported ROE, as the denominator in the ROE calculation increased. However, the impact of the net loss in 2024 was partially offset by the existing equity base, preventing a more drastic decline in ROE. The slight decrease in reported shareholders’ equity from 2023 to 2024 did contribute to the larger decline in reported ROE during that year.
Overall, the financial performance demonstrated volatility during the analyzed period. While ROE generally recovered in 2025, the significant loss in 2024 warrants further investigation to understand the underlying factors contributing to the decline in profitability.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income (loss) ÷ Adjusted total assets
= 100 × ÷ =
The period between 2021 and 2025 demonstrates fluctuating performance as measured by reported and adjusted return on assets. Reported net income and adjusted net income generally increased from 2021 to 2023, followed by a significant decline in 2024, and a subsequent recovery in 2025. Total assets, both reported and adjusted, exhibited a consistent upward trend throughout the period, although the rate of growth slowed in 2024 and 2025.
- Reported Return on Assets (ROA)
- Reported ROA increased from 17.44% in 2021 to 18.30% in 2022, before decreasing to 15.92% in 2023. A substantial decline was observed in 2024, with ROA falling to -2.38%. The metric then recovered to 15.42% in 2025. This volatility suggests a sensitivity to changes in net income, particularly the significant loss experienced in 2024.
- Adjusted Return on Assets (ROA)
- Adjusted ROA mirrored the trend of the reported ROA, increasing from 17.50% in 2021 to 18.02% in 2022, decreasing to 14.74% in 2023, and experiencing a sharp decline to -4.38% in 2024. A recovery to 15.13% was noted in 2025. The adjusted ROA consistently remained slightly below the reported ROA throughout the period, indicating that adjustments to net income and total assets generally resulted in a marginally lower profitability metric.
- Relationship between Net Income and ROA
- The substantial decrease in both reported and adjusted ROA in 2024 directly correlates with the reported net loss and adjusted net loss for that year. This highlights the significant impact of profitability on the ROA calculation. The recovery in ROA in 2025 aligns with the return to positive net income.
- Asset Base Impact
- While total assets increased consistently, the impact on ROA was moderated by fluctuations in net income. The slower growth in asset increases during 2024 and 2025 may have partially contributed to the ROA recovery in 2025, as the denominator in the ROA calculation grew at a slower pace while net income improved.
In summary, the period was characterized by generally positive performance in the initial years, followed by a significant downturn in 2024 and a partial recovery in 2025. The ROA metrics, both reported and adjusted, were heavily influenced by net income fluctuations, demonstrating the importance of profitability in driving asset utilization efficiency.